Emmes Recognized in New Research Published by the Journal of the American Medical Association
Dr. Traci Clemons was one of the Authors and Study Investigators
ROCKVILLE, Md., Aug. 27, 2015 /PRNewswire-USNewswire/ — The Emmes Corporation today announced that one of its principal investigators and statisticians, Dr. Traci Clemons, co-authored a study that was just published by the Journal of the American Medical Association (JAMA).  The researchers had conducted a five-year study with 4,000 patients to determine whether omega-3 and other nutritional supplements are associated with cognitive function.  Dr. Clemons had led the Emmes team doing the clinical trials associated with the study.
The results of the study showed that neither omega-3 supplements nor other vitamins, such as vitamin C, E, beta carotene, lutein/zeaxanthin, or zinc, slowed the progress of cognitive decline.  The study was one of the largest and longest of its kind and was published in the JAMA’s August 25 issue.
“Although there are positive benefits from a diet of foods containing omega-3 and antioxidants, the study did not prove that dietary supplements could slow the progress of cognitive decline,” said Dr. Clemons.
Dr. Clemons credited Dr. Emily Chew, the primary author of the study, with her initiative in broadening the focus of the prior work that Dr. Clemons and the Emmes team had done for the National Eye Institute.  Dr. Chew was the lead author of the study and is the deputy director of the Division of Epidemiology and Clinical Applications at the National Eye Institute.
“Our original focus was to test the effect of these supplements on eye disease,” noted Dr. Clemons.  “Dr. Chew worked to broaden the study so that it could address cognitive decline, not to mention issues like cardiovascular disease and mortality.  Including other parts of the National Institutes of Health and doing cross-disease research makes a lot of sense, from both a time and cost standpoint,” she added.
The National Eye Institute, part of the National Institutes of Health, awarded Emmes its first Age-Related Eye Disease Study (AREDS) contract in 1990.  Emmes tested whether high doses of antioxidants and zinc would slow age-related macular degeneration, one of the leading causes of blindness…….
Read more: http://www.prnewswire.com/news-releases/emmes-recognized-in-new-research-published-by-the-journal-of-the-american-medical-association-300133993.html
Source: PR Newswire